Date of publication: December 1,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/NL/06/07
Member State
Netherlands
Date of Acknowledgement
08/05/2006 00:00:00
Title of the Project
Application for the deliberate release
of genetically modified DAS-Ø15Ø7-1xMON-ØØ6Ø3-6 (1507xNK603)
maize.
Proposed period of release:
01/04/2007 00:00:00 to 31/12/2010
00:00:00
Name of the Institute(s) or
Company(ies)
Pioneer Hi-Bred Northern Europe Sales
Division GmbH, ;
3. Is the same GMPt release planned
elsewhere in the Community?
Yes:
Has the same GMPt been notified
elsewhere by the same notifier?
No
Genetically modified plant
Complete name of the recipient or
parental plant(s)
|
Common Name |
Family Name |
Genus |
Species |
Subspecies |
Cultivar/breeding line |
| maize |
poaceae |
zea |
zea mays |
mays |
|
2. Description of the traits and
characteristics which have been introduced or modified,
including marker genes and previous modifications:
The genetically modified 1507xNK603
maize varieties that will be tested in these field trials are
resistant to certain Lepidopteran insects, such as the European
corn borer (Ostrinia nubilalis) and tolerant to
glufosinate-ammonium and glyphosate herbicides. This maize was
derived through traditional breeding methods between progeny of
the genetically modified 1507 maize, which is resistant to
certain lepidopteran insects and tolerant to glufosinate
herbicide, and NK603 maize (from Monsanto), which is tolerant to
glyphosate herbicide.
Genetic modification
3. Type of genetic modification:
Insertion;
In case of insertion of genetic
material, give the source and intended function of each
constituent fragment of the region to be inserted:
The genes introduced in 1507xNK603
maize are the cry1F gene from Bacillus thuringiensis var.
aizawai, providing resistance to certain Lepidopteran insects
and the pat gene from Streptomyces viridochromogenes, introduced
as a selectable marker, providing tolerance to
glufosinate-ammonium herbicide, like in 1507 maize, and the
cp4epsps gene from Agrobacterium sp. strain CP4 that confers
tolerance to glyphosate herbicide, like in NK603 maize, along
with their regulatory components necessary for expression in
maize plant:
- the cry1F gene, the UBIZM1(2) promoter, the ORF25PolyA
terminator.
- the pat gene, the CaMV35S promoter, the CaMV35S terminator.
- the cp4epsps gene, the P-ract1/ract1 intron + ctp2, the NOS 3’
terminator.
- the cp4epsps gene, the CaMV e35S promoter + Zmhsp70 + ctp2,
the NOS 3’ terminator
6. Brief description of the method
used for the genetic modification:
No genetic modification was made on the
1507xNK603 maize varieties directly: they were derived through
traditional breeding methods between progeny of the genetically
modified 1507 maize and NK603 maize.
1507 maize and NK603 maize (from Monsanto) were genetically
modified using the particle acceleration method.
7. If the recipient or parental plant
is a forest tree species, describe ways and extent of
dissemination and specific factors affecting dissemination:
Not applicable
Experimental Release
1. Purpose of the release:
The purpose of the release is to verify
the behavior of 1507xNK603 maize under glyphosate applications.
2. Geographical location of the site:
Site 1: Venray
Site 2: Werkendam
Site 3: Haaksbergen
3. Size of the site (m2):
Each site could have up to 10000 m²
sown with the genetically modified maize subject of this
notification (1507xNK603 maize).
4. Relevant data regarding previous
releases carried out with the same GM-plant, if any,
specifically related to the potential environmental and human
health impacts from the release:
Field trials have already been
conducted at several locations across maize growing regions in
North America, South America and Europe and no environmental
problems were reported for these trials. The transgenic plants
were indistinguishable from the non-genetically modified maize
plants except for showing resistance to certain Lepidopteran
insects such as Ostrinia nubilalis and showing tolerance when
glufosinate and glyphosate herbicides have been applied, traits
due to the genetic modifications.
Environmental Impact and Risk
Management
Summary of the potential environmental
impact from the release of the GMPts:
No risks to human and animal health or
the environment from the deliberate release of genetically
modified maize resistant to certain Lepidopteran insects and
tolerant to glufosinate and glyphosate herbicides are expected,
as per information contained in the environmental risk
assessment included in the notification.
Brief description of any measures
taken for the management of risks:
The shedding of pollen from the
genetically modified plants will be controlled by maintaining a
250-meter isolation distance with any other non-experimental
maize crop. In addition, the trial site will be surrounded by
four border rows of conventional maize of a similar relative
maturity that will be also destroyed at the end of the release.
Seed dispersal of individual kernels does not generally occur.
They are fixed on a cob and enclosed in many husks that protect
the seeds from outside contact. When a few seeds need to be
collected for analysis, this will be done by sampling the whole
ear and unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by
mechanical destruction, or by application of a non-selective
herbicide, other than glufosinate and glyphosate, and
incorporation into the soil.
At the end of the release, all remaining plant matter that has
not been harvested for analyses will be destroyed by chopping
and incorporating into the soil by deep ploughing.
No plant or plant product coming from the trials will enter the
food or feed chains.
After the release, the plot will be visited regularly during the
following year in order to ensure removal of maize volunteers,
if any. Although volunteer maize cannot generally survive hard
winter, maize volunteers, if any, will be monitored in order to
ensure their destruction.
There will be no commercial maize grown on the same area of the
field the following year.
Summary of foreseen field trial
studies focused to gain new data on environmental and human
health impact from the release:
Not applicable to this release.
Final report
-
European Commission administrative
information
Consent given by the Competent
Authority:
Not known |
